X
Record #58870

Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer

Original paper date
Nov 14, 2022
Institution
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia · Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia · Department of Urology, Universiti Putra Malaysia, 43400, Selangor, Malaysia · Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, 21589, Saudi Arabia · Department of Pharmaceutics, and Industrial Pharmacy, Faculty, of Pharmacy, Minia University, Minia, Egypt · Department of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia · Department of Pharmaceutics and Industrial Pharmacy, Cairo University, Cairo, 11562, Egypt · Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah, 21589, Saudi Arabia · Mohamed Saeed Tamer Chair for Pharmaceutical Industries, King Abdulaziz University, Jeddah, 21589, Saudi Arabia
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cancer(BLS) Biology - Cellular(HSC) Medicine - Pharmacology(PHY) Nanotechnology
Notes from Retraction Watch

see also: https://pubpeer.com/publications/971CD2F8DC02285EE1203F77C7DF56

Citation lifecycle

How this paper is being cited

Pre-retraction
5
Same day
0
Post-retraction
1
% post-retraction
16.7%
~2.5 citations/yr before retraction · ~0.5 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse